Dr. Ambinder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964Fax+1 410-955-0960- Is this information wrong?
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 1979 - 1982
- Johns Hopkins University School of MedicineClass of 1979
- Johns Hopkins UniversityFellowship, Medical Oncology
Certifications & Licensure
- VA State Medical License 2023 - 2026
- MD State Medical License 1979 - 2024
- PA State Medical License 2020 - 2022
- MI State Medical License 1980 - 1982
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Valproic Acid in Treating Patients With Kaposi's Sarcoma Start of enrollment: 2005 Feb 01
- Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD Start of enrollment: 2003 Jan 01
- Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Nelfinavir inhibition of Kaposi's sarcoma-associated herpesvirus protein expression and capsid assembly.Maggie Li, Barbara J Smith, Jaeyeun Lee, Jennifer Petr, Nicole M Anders, Robyn Wiseman, Michelle A Rudek, Richard F Ambinder, Prashant J Desai> ;Infectious Agents and Cancer. 2024 Mar 4
- Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients.Skoloda, D., Newman, M., Norman, H., Ziggas, J., Ambinder, R.> ;JCO Oncology Practice. 2024 Feb 21
- Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-...Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, Ronald T Mitsuyasu, Michelle A Rudek, Aboulafia, D., Ratner, L., Ambinder, R., Baiocchi, R., Wachsman, W., Sparano...> ;Clinical Cancer Research. 2023 Dec 15
- Join now to see all
Abstracts/Posters
- Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's LymphomaRichard F. Ambinder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatm...Richard F. Ambinder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...Richard F. Ambinder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Cytomegalovirus Reactivation in Haploidentical Blood or Marrow Transplant (BMT) Using Post-Transplant Cyclophosphamide (PTCy) Is Associated with Higher Non-Relapse-Rel...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- 5th Annual T-cell Lymphoma ForumJonathan Wood & Associates, San Francisco, California - 1/24/2013
Other
- Development of malignancy following solid organ transplantationAmbinder RF, Brennan DC, Rodeheffer RJ
http://www.uptodate.com/contents/development-of-malignancy-following-solid-organ-transplantation
UpToDate, Wolters Kluwer Health - 2013-04-18 - The role of Epstein-Barr virus in Hodgkin lymphomaAmbinder RF
http://www.uptodate.com/contents/the-role-of-epstein-barr-virus-in-hodgkin-lymphoma
UpToDate, Wolters Kluwer Health - 2012-06-26 - Systemic therapy for malignancy in patients on anti retroviral medicationsAmbinder RF, Flexner CW, Deeken JF, Rudek MA
http://www.uptodate.com/contents/systemic-therapy-for-malignancy-in-patients-on-anti-retroviral-medi
UpToDate, Wolters Kluwer Health - 2012-08-16
Press Mentions
- Combination Immunotherapy Shows High Activity Against Recurrent Hodgkin LymphomaDecember 3rd, 2018
- HIV-Associated Cancers: A Paradigm Shift?April 19th, 2018
- Liquid Biopsies Study Boosts Cancer Detection HopeAugust 17th, 2017
- Join now to see all
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/richard-ambinder
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: